Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Osoba

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical OncologyR J Gralla, D Osoba, M G Kris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patientsJ Maringwa, C Quinten, M King, et al.
British Journal of Cancer|August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseW K Yung, R E Albright, J Olson, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical OncologyR J Gralla, D Osoba, M G Kris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patientsJ Maringwa, C Quinten, M King, et al.
British Journal of Cancer|August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseW K Yung, R E Albright, J Olson, et al.
Pageof 13